Is Noxi Rise a Scam?

When we at FXCanary evaluate a broker, we start from a position of healthy scepticism and work outward from verifiable facts. Our safety framework weighs three pillars: regulatory oversight, operational transparency, and the practical protections available to clients if something goes wrong. A broker that scores well on all three earns our confidence; one that falls short on any of them warrants caution, regardless of how polished its website or marketing materials appear.

For Noxi Rise, our assessment begins with a significant handicap: the broker has no verified regulatory licence on file, and our records show zero regulators and zero licences. This is not a minor omission — it is the single most important factor in our safety evaluation. Without a recognised regulator, there is no independent authority monitoring the firm's conduct, no mandatory client-fund segregation regime, and no compensation scheme to fall back on if the broker fails or disappears. Our FXCanary Scam Risk Score of 55/100 reflects this elevated risk profile, driven by two specific flags: no verified regulatory licence and no verifiable website or social-media presence beyond the broker's own domain.

In jurisdictions with robust oversight — such as the UK, Cyprus, or Australia — brokers must hold a licence, segregate client funds from their own operating capital, and participate in compensation schemes that protect investors up to a certain threshold. These protections are not optional; they are enforced by regulators with the power to audit, fine, and shut down non-compliant firms. When a broker operates without any such licence, none of these safeguards apply.

For Noxi Rise, the absence of a licence means that if the company were to mishandle funds, freeze withdrawals, or simply cease operations, clients would have no regulatory ombudsman to complain to and no compensation fund to recover losses. The broker's own risk disclosure acknowledges that trading CFDs is highly speculative and that clients may lose all or more than their initial capital — but that warning covers market risk, not the risk of broker failure. In our view, the latter risk is unacceptably high when there is no regulator watching over the firm.

Our review of the broker's public documentation reveals a registered office in Mutsamudu, Anjouan, in the Union of Comoros, under the legal entity name District Hold Ltd. The Comoros is not a jurisdiction known for robust financial regulation or investor protection. While offshore registration is not inherently fraudulent, it is a common feature of brokers that seek to avoid the compliance burdens and oversight of major financial centres.

We cross-checked this information against our records, which list the country of registration as 'unknown' — a discrepancy that itself raises questions about the completeness and reliability of the broker's disclosures. The fact that the broker's own website provides a Comoros address, while our records cannot confirm even the country of registration, suggests a lack of transparency that we find concerning. For a trader, this means there is no clear legal jurisdiction in which to seek recourse if a dispute arises.

Even among regulated brokers, the level of client-fund protection varies. In the EU, for example, client funds must be segregated and are covered by investor compensation schemes up to €20,000. In the UK, the Financial Services Compensation Scheme covers up to £85,000. These schemes are funded by levies on regulated firms and provide a safety net that is absent for clients of unregulated brokers.

For Noxi Rise, we found no evidence of client-fund segregation, no participation in any compensation scheme, and no independent audit of its financial practices. The broker's website mentions negative balance protection, which is a useful feature that prevents clients from owing more than their deposit in volatile markets. However, this is a contractual promise, not a regulatory requirement, and its enforceability is questionable when the broker itself is not subject to oversight. In our assessment, the absence of these protections is a critical gap that should give any potential client pause.

A further layer of risk for Noxi Rise comes from the potential for clone sites and impersonation. Our records show no confirmed clone or impersonator sites for this broker, which is a small positive. However, the broker's name is not distinctive, and we found multiple domains in our web search results — such as NoxiRise-ltd.net and Noxirise-ltd.com — that appear to be associated with the brand but are not the official domain we have on file (noxirise.com).

This proliferation of similar domains is a red flag. It could indicate that the broker operates through multiple fronts, or it could mean that third parties are creating lookalike sites to deceive traders. Either way, it complicates the task of verifying which entity a trader is actually dealing with. We advise any trader considering Noxi Rise to confirm they are on the official domain and to be wary of any unsolicited contact from 'Noxi Rise' representatives, as such approaches are a common tactic in phishing and advance-fee scams.

Noxi Rise's website makes bold claims: 'institutional-grade trading', access to 160+ assets, deep liquidity, and an 80% IB revenue share. It also presents an 'Attestation of Compliance' claiming alignment with PCI DSS v4.0 for payment security. We treat these claims with caution. PCI DSS compliance, even if genuine, relates to payment card security and says nothing about the broker's financial soundness or regulatory status.

More importantly, we found no independent verification of any of these claims. The broker has no user reviews on independent platforms, and our web search results returned only promotional articles and the broker's own pages. In the absence of third-party validation, we cannot confirm the quality of execution, the depth of liquidity, or the reliability of withdrawals. For a broker with no regulatory oversight, such unverifiable claims are a significant concern.

If you are still considering Noxi Rise despite the risks, we strongly recommend taking additional precautions. First, verify the broker's identity and registration independently. Ask for its legal entity name, registration number, and the regulator that oversees it. If the broker cannot provide this information, or if the regulator cannot be confirmed, treat that as a decisive negative.

Second, start with a minimal deposit — an amount you can afford to lose entirely. Do not transfer funds until you have tested the platform with a demo account and confirmed that withdrawals work as advertised. Third, use a separate payment method, such as a credit card or a dedicated e-wallet, that offers some form of chargeback protection. Finally, monitor your account regularly and be alert to any pressure to deposit more money or to 'upgrade' your account. These are common tactics in the early stages of a scam.

In FXCanary's assessment, Noxi Rise presents an elevated risk profile that is not suitable for most retail traders. The absence of any regulatory licence, the offshore registration in the Comoros, and the lack of independent reviews or verifiable operational history combine to create a picture of a broker that operates outside the safeguards of the regulated financial system.

We cannot say definitively that Noxi Rise is a scam — our records show no confirmed fraud or clone sites — but the burden of proof is on the broker to demonstrate its legitimacy. Until it provides verifiable regulatory details and a track record that can be independently checked, we advise traders to treat Noxi Rise with extreme caution. The potential for loss is not limited to market movements; it includes the risk that the broker itself may not honour its obligations. For most traders, there are better-regulated alternatives that offer comparable features without the same level of risk.